Classification of Pathologic Response to Neoadjuvant Therapy in Esophageal and Junctional Cancer

Abstract

No existing response measure independently predicts outcome. A complete response (TRG 1) defines a unique cohort after neoadjuvant therapy, associated closely with nodal response, and overall survival. This classification merits consideration for standardization of treatment response, and for inclusion in staging nomenclature.